IMPORTANCE
The frequency and characteristics of post-acute sequelae of SARS-CoV-2 infection (PASC) may vary by SARS-CoV-2 variant.
OBJECTIVE
To characterize PASC-related conditions among individuals likely infected by the ancestral strain in 2020 and individuals likely infected by the Delta variant in 2021.
DESIGN
Retrospective cohort study of electronic medical record data for approximately 27 million patients from March 1, 2020-November 30, 2021.
SETTING
Healthcare facilities in New York and Florida.
PARTICIPANTS
Patients who were at least 20 years old and had diagnosis codes that included at least one SARS-CoV-2 viral test during the study period.
EXPOSURE
Laboratory-confirmed COVID-19 infection, classified by the most common variant prevalent in those regions at the time.
MAIN OUTCOMES AND MEASURES
Relative risk (estimated by adjusted hazard ratio [aHR]) and absolute risk difference (estimated by adjusted excess burden) of new conditions, defined as new documentation of symptoms or diagnoses, in persons between 31-180 days after a positive COVID-19 test compared to persons with only negative tests during the 31-180 days after the last negative test.
RESULTS
We analyzed data from 560,752 patients. The median age was 57 years; 60.3% were female, 20.0% non-Hispanic Black, and 19.6% Hispanic. During the study period, 57,616 patients had a positive SARS-CoV-2 test; 503,136 did not. For infections during the ancestral strain period, pulmonary fibrosis, edema (excess fluid), and inflammation had the largest aHR, comparing those with a positive test to those with a negative test, (aHR 2.32 [95% CI 2.09 2.57]), and dyspnea (shortness of breath) carried the largest excess burden (47.6 more cases per 1,000 persons). For infections during the Delta period, pulmonary embolism had the largest aHR comparing those with a positive test to a negative test (aHR 2.18 [95% CI 1.57, 3.01]), and abdominal pain carried the largest excess burden (85.3 more cases per 1,000 persons).
CONCLUSIONS AND RELEVANCE
We documented a substantial relative risk of pulmonary embolism and large absolute risk difference of abdomen-related symptoms after SARS-CoV-2 infection during the Delta variant period. As new SARS-CoV-2 variants emerge, researchers and clinicians should monitor patients for changing symptoms and conditions that develop after infection.
STATEMENTS AND ACKNOWLEDGEMENTS
Authorship has been determined by ICJME recommendationDisclosures to be obtained at time of submissionThe content is solely the responsibility of the authors and does not necessarily represent the official views of the RECOVER Program, the NIH or other fundersWe would like to thank the National Community Engagement Group (NCEG), all patient, caregiver and community Representatives, and all the participants enrolled in the RECOVER Initiative.